KOSPIRetail & Consumer122900

iMarketKorea

₩8,160▼ 0.12%2026-11-18 close
Market Cap
₩272.8B
Turnover
₩300M
Volume
40K
Shares out.
33.4M
PER
5.2×
PBR
0.7×
EPS
₩1,565
Dividend Yield
5.49%

PER, EPS, PBR and BPS are calculated in-house from the last 4 quarters (2025Q4–2026Q3) · Dividend yield is based on ₩450 per share · Prices as of the 2026-11-18 close

01

Report overview

Profit recovery in MRO distribution faces a durability test

iMarketKorea's annual sales and operating profit fell for three straight years through 2025, but quarterly sales have risen for four consecutive quarters through the third quarter of 2026 after a return to operating profit.

  1. 1

    Operating profit fell from KRW 56.3 billion in 2022 to KRW 20.3 billion in 2025, and the operating margin dropped from 1.6% to 0.7%.

  2. 2

    Operating profit in the third quarter of 2026 reached KRW 21 billion, up 157.0% from a year earlier, and has increased for two straight quarters since turning profitable in the first quarter of 2026.

  3. 3

    Net income attributable to controlling shareholders totaled KRW 49.2 billion over the last four quarters, from the fourth quarter of 2025 through the third quarter of 2026.

  4. 4

    The debt-to-equity ratio was 223.2% in 2025, higher than 198.6% in 2022, with total liabilities of KRW 942 billion.

  5. 5

    Operating cash flow swung from -KRW 2.4 billion in 2024 to KRW 52.6 billion in 2025.

02

Business structure

iMarketKorea was founded in 2000 for industrial B2B e-commerce and its core business is MRO (maintenance, repair and operations) procurement outsourcing.

According to Butler's compilation, industrial consumables e-commerce accounted for 74% of second-quarter 2026 sales, pharmaceutical wholesale for 23%, and other businesses for 3%. Its healthcare arm, Ahn Care, acquired in 2014, handles distribution of pharmaceuticals and medical consumables.

Corporate information services describe the company as a major MRO distributor serving large and mid-sized corporate buyers. Its main platform, IMKMall, handles corporate purchasing online and is being upgraded for security and user experience. The company is known for a fee-based revenue model.

Overseas, it operates subsidiaries in Vietnam, China and the United States. In July 2026 it was designated a specialized trading company to expand overseas sales support for domestic manufacturers.

In Texas it is pursuing a mixed-use industrial complex, with a first development phase planned to start construction in 2025. Its distribution scope has also expanded into construction materials, IT and pharmaceuticals. Competition in the MRO market has intensified as online distribution platforms grow.

03

Earnings trend

Quarterly revenue · Operating profit
RevenueOperating profit
Annual revenue · Operating profit
RevenueOperating profit
Quarterly results · Last 5 quarters
QuarterRevenueOperating profitOp. margin
2025Q3₩764B₩8.2B1.1%
2025Q4₩807.4B-₩4.1B−0.5%
2026Q1₩842.5B₩16.6B2.0%
2026Q2₩1T₩17.7B1.8%
2026Q3₩1.1T₩21B2.0%
Annual results
YearRevenueOperating profitNet income (parent)Op. marginROEDebt-to-equity
2022₩3.6T₩56.3B₩22.2B1.6%6.2%198.6%
2023₩3.4T₩51.1B₩15.1B1.5%4.4%243.1%
2024₩3.3T₩44.8B₩27B1.3%7.5%208.6%
2025₩3.1T₩20.3B₩20.9B0.7%5.7%223.2%

Consolidated basis (financial statements including subsidiaries) · Final figures from DART filings · Net income attributable to owners of the parent · Data as of 2026-11-17

04

Earnings analysis

On a reported basis, annual sales fell from KRW 3.59 trillion in 2022 to KRW 3.43 trillion in 2023 (down 4.5% year on year), KRW 3.32 trillion in 2024 (down 3.1%) and KRW 3.05 trillion in 2025 (down 8.0%), a decline that has run for three straight years since 2022. 2022 was the largest year in the period and 2025 the smallest.

Operating profit fell from KRW 56.3 billion in 2022 to KRW 51.1 billion in 2023 (down 9.2%), KRW 44.8 billion in 2024 (down 12.4%) and KRW 20.3 billion in 2025 (down 54.6%), and the operating margin slipped from 1.6% to 1.5%, 1.3% and 0.7%.

Operating profit fell far faster than sales, which points to margin compression as the main driver of the annual decline.

Based on FnGuide's cash flow statement, provisions for doubtful accounts rose from KRW 1.6 billion in 2024 to KRW 22 billion in 2025, and selling expenses rose from KRW 3.6 billion to KRW 23.1 billion.

Net income attributable to controlling shareholders fell from KRW 22.2 billion in 2022 to KRW 15.1 billion in 2023 (down 31.9%), rebounded to KRW 27 billion in 2024 (up 78.2%) and was KRW 20.9 billion in 2025 (down 22.3%).

The 2024 rebound appears to reflect financial income rising from KRW 10.2 billion in 2023 to KRW 29.1 billion in 2024 while operating profit was falling. Net income including non-controlling interests was KRW 29.6 billion in 2025, a different figure from net income attributable to controlling shareholders.

On a quarterly basis, the third quarter of 2025 showed sales of KRW 764 billion and operating profit of KRW 8.18 billion. The fourth quarter brought sales of KRW 807.4 billion (up 5.7% quarter on quarter) and an operating loss of KRW 4.13 billion, a swing into deficit.

The third quarter of 2026 delivered sales of KRW 1.08 trillion and operating profit of KRW 21 billion (up 157.0% year on year).

Operating profit of KRW 16.6 billion in the first quarter of 2026 was a return to profit from the prior quarter's loss, and net income attributable to controlling shareholders rose for three straight quarters from KRW 4.54 billion in the fourth quarter of 2025 to KRW 18.3 billion in the third quarter of 2026.

Operating profit for January to September 2026 of KRW 55.3 billion is a preliminary figure announced on November 9, 2026.

05

Industry analysis

Industrial B2B e-commerce is seen as relatively insensitive to the business cycle, yet demand from industrial customers weakened in 2025 and limited sales and profitability. The shift by corporate buyers toward platform-based MRO outsourcing to improve purchasing efficiency is a structural tailwind for iMarketKorea.

On the other hand, the growth of online distribution platforms has intensified competition for pricing and customer acquisition in the MRO market. The company points to its large and mid-sized corporate customer base and its IT system upgrades as strengths.

Listed peers in the same consumer and distribution sector include LX International, POSCO International and SKNetworks, but detailed disclosures for direct comparison of scale and profitability are not covered here.

Quarterly sales growth widened in 2026, yet disclosures alone cannot tell whether this came from a recovery in industrial demand or from new customers and product expansion.

The pharmaceutical wholesale business has a different demand structure from industrial supply and should be assessed against medical distribution competition. Judging the sector outlook requires tracking industrial demand indicators alongside changes in customers' procurement volumes.

06

Outlook

Three business plans are confirmed. The first is the Texas industrial complex, with a first development phase planned to start construction in 2025. The second is the July 2026 designation as a specialized trading company, aimed at expanding overseas sales support for domestic manufacturers.

The third is the upgrade of the IMKMall platform and expansion into new distribution areas such as healthcare and construction materials. Reports also mention entry into EV charging infrastructure operations, but there is limited information on its scale.

On shareholder returns, the company decided on a quarterly cash dividend in a disclosure on November 9, 2026. On operating results, third-quarter 2026 operating profit of KRW 21 billion rose from KRW 17.7 billion in the second quarter.

The January to September 2026 operating profit figure is preliminary and was released before external audit review was complete. The Texas project links to fixed asset expansion, so higher investment could raise depreciation and borrowing needs.

The healthcare business is a key variable for the profitability of pharmaceutical wholesale. The next checkpoints are the fourth-quarter and full-year 2026 results, followed by the operating margin and sales mix in the 2026 annual report.

07

Valuation

PER
5.2×
PBR
0.7×
ROE
12.8%
EPS
₩1,565
BPS
₩12,542
Dividend per share
₩450

Measured against net income attributable to controlling shareholders of KRW 49.2 billion over the last four quarters, the market capitalization sits at a relatively low multiple of earnings.

The price-to-book ratio is below 1x, meaning the market value trades under the net asset value attributable to controlling shareholders of KRW 370 billion.

In 2024, the share price and earnings followed a different path from today, so the current multiple is more meaningful when read together with the pace of earnings recovery. The dividend yield is relatively high versus the market value, since the company declares a cash dividend each quarter.

Dividends can change with earnings, which should be kept in mind. The key variable in valuation is the durability of operating profit, which fell to KRW 20.3 billion in 2025. Two consecutive quarters of higher operating profit in 2026 do not alone establish that earnings power has fully recovered.

The debt-to-equity ratio of 223.2% and total liabilities of KRW 942 billion also need to be read alongside the multiples. How the earnings and book value multiples move can be followed together with the operating margin disclosed in the next annual report.

PER, EPS, PBR and BPS are all calculated in-house (the same method as Naver and Toss) · Dividend yield = cash dividend per share from DART filings (supplemented by KRX) ÷ current price · As of 2026-11-17

08

Bull factors

Quarterly earnings have turned

After an operating loss of KRW 4.13 billion in the fourth quarter of 2025, operating profit returned to KRW 16.6 billion in the first quarter of 2026. Third-quarter 2026 operating profit of KRW 21 billion rose 157.0% year on year.

Quarterly sales have risen for four consecutive quarters, and net income attributable to controlling shareholders has increased for three straight quarters to KRW 18.3 billion.

Operating cash flow recovered

Operating cash flow turned from negative in 2024 to positive in 2025. It remains below the KRW 90.3 billion recorded in 2023, but the company has moved out of the negative range. Total equity stood at KRW 422.1 billion, of which KRW 370 billion belongs to controlling shareholders.

Diversification and shareholder returns

The healthcare subsidiary Ahn Care and pharmaceutical wholesale make up 23% of sales in the second quarter of 2026, per Butler. The July 2026 designation as a specialized trading company expands overseas sales support.

A quarterly cash dividend was decided in a November 9, 2026 disclosure, continuing the shareholder return practice.

09

Bear factors

Long-term profitability decline

The operating margin declined from 1.6% in 2022 to 1.5% in 2023, 1.3% in 2024 and 0.7% in 2025. Operating profit fell from KRW 56.3 billion in 2022 to KRW 20.3 billion in 2025. Margin compression overlapped with sales declines that have run for three straight years.

High debt load

The debt-to-equity ratio was 223.2% in 2025, higher than 198.6% in 2022 and after peaking at 243.1% in 2023. Total liabilities of KRW 942 billion exceed twice total equity of KRW 422.1 billion. Financing costs could amplify earnings volatility.

Competition and bad-debt costs

Growth of online distribution platforms has intensified competition in the MRO market. Provisions for doubtful accounts rose to KRW 22 billion in 2025 from KRW 1.6 billion in 2024. Selling expenses also rose from KRW 3.6 billion to KRW 23.1 billion over the same period.

10

Risk factors

Earnings quality and reliance on financial income

The 2024 rebound in net income attributable to controlling shareholders was driven largely by financial income rising to KRW 29.1 billion, while operating profit fell to KRW 44.8 billion that year. Financial income stayed near KRW 31.1 billion in 2025.

If the contributions of operating profit and financial income diverge, the direction of net income can change, so the operating profit trend should be tracked alongside it.

Receivables and bad-debt risk

Trade and other current receivables stood at KRW 666.8 billion at the end of March 2026, a large share of total assets. With provisions for doubtful accounts rising to KRW 22 billion in 2025, customer credit management directly affects profit. Longer collection periods or renewed bad-debt charges could push the operating margin lower.

Overseas investment and fixed asset expansion

Property, plant and equipment rose from KRW 140 billion in 2023 to KRW 223.7 billion at the end of March 2026. Full-scale development of the Texas industrial complex could enlarge the investment base further.

Overseas operations are exposed to exchange rates and local economic conditions, and delayed returns could weigh on profit through depreciation and borrowing costs.

11

What to watch next

  1. Around February 2027 (estimated from prior-year timing)

    Release of fourth-quarter and full-year 2026 results. This shows whether profitability continues after the fourth quarter of 2025 loss and how far operating profit recovers from KRW 20.3 billion in 2025.

  2. Late March 2027

    Filing of the 2026 annual report, due by the statutory deadline. Audited financial statements will confirm the 2026 preliminary figures, and operating margin, debt ratio and bad-debt trends can be checked on an audited basis.

  3. Around mid-May 2027 (estimated from prior-year timing)

    Release of first-quarter 2027 results. The first-quarter 2026 operating profit of KRW 16.6 billion serves as the benchmark for whether the quarterly trend and sales growth are sustained.

12

Overall view

iMarketKorea began this period with sales and operating profit both declining since 2022, pulling the operating margin from 1.6% to 0.7%. After an operating loss in the fourth quarter of 2025, it returned to profit in the first quarter of 2026.

Third-quarter 2026 operating profit of KRW 21 billion rose 157.0% year on year, and net income attributable to controlling shareholders totaled KRW 49.2 billion over the last four quarters. Operating cash flow recovered to KRW 52.6 billion in 2025.

On the other side, the debt-to-equity ratio of 223.2% in 2025 is higher than in 2022, and provisions for doubtful accounts and selling expenses both rose in 2025, so the quality of earnings needs confirmation. The 2024 rebound in net income relied on financial income, which matters when reading the annual trend.

Planned projects such as the Texas complex, the specialized trading company designation and the healthcare subsidiary are confirmed, but their scale and profit contribution are not yet clear from disclosures.

The next checkpoints are fourth-quarter and full-year 2026 results, along with the operating margin and debt level in the 2026 annual report.

13

Sources

  1. Korea Exchange (KRX) — Prices · Market Cap · Volume
  2. FSS electronic disclosure system (DART) — Financial statements · Dividend filings
Show 18 more articles and sources
  1. digitaltoday.co.kr
  2. jobkorea.co.kr
  3. comp.wisereport.co.kr
  4. thevc.kr
  5. butler.works
  6. digitaltoday.co.kr
  7. calculator.io.kr
  8. jasoseol.com
  9. innoforest.co.kr
  10. vegannews.co.kr
  11. tipranks.com
  12. edaily.co.kr
  13. kr.investing.com
  14. edaily.co.kr
  15. edaily.co.kr
  16. edaily.co.kr
  17. comp.fnguide.com
  18. edaily.co.kr

Report written 2026-11-18 · Data as of 2026-11-17

This content is AI analysis of market data and web search results, provided for information only. It is not a solicitation or recommendation to invest. Investment decisions and their consequences are the investor's own responsibility. Data may be delayed or contain errors.

Other reports in this industry

View industry analysis